Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Immunol. 2002 Dec;14(6):698-704.

Inhibitory receptors and allergy.

Author information

  • Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. hrkatz@mbcrr.harvard.edu

Abstract

Recent studies of the major cell types involved in the initiation and progression of allergic inflammation have revealed that they express an unexpectedly large number of surface receptors that inhibit the release of proinflammatory mediators from mast cells and basophils in vitro. Moreover, analyses of animals deficient in some of these receptors, for example, Fc(gamma)RIIB, gp49B1 and paired Ig-like receptor (PIR)-B, have shown that the molecules indeed suppress allergic responses driven by the adaptive immune response in vivo. These findings support the emerging concept that allergic diseases are caused not only by excessive activation of cells but also from deficiencies in receptors that suppress these activation responses.

PMID:
12413518
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk